Adalimumab: all 321 studies that test it

Page 2 of 4. Open to participants first (39), then studies with results posted, then the rest; newest registration first within each.

• Study in Rheumatoid Arthritis for Subjects Who Completed Preceding Study M13-390 With AdalimumabCompletedNCT01752855Phase 2Results posted
• Pharmacokinetics of Adalimumab With Methotrexate for Treatment of Patients With Ulcerative Colitis (UC)TerminatedNCT01716039Phase 2Results posted
• Addition of Modulators of Homocysteine to Adalimumab Therapy in the Treatment of Moderate to Severe Plaque PsoriasisTerminatedNCT01704599Phase 1/2Results posted
• Safety and Efficacy Study of Adalimumab in the Treatment of Plaque PsoriasisCompletedNCT01646073Phase 3Results posted
• An Open-Label, Prospective Study to Assess the Safety and Effectiveness of Adalimumab in Patients With Moderate to Severe Plaque Psoriasis in the Russian FederationCompletedNCT01644396Phase 4Results posted
• Open-label Study of the Safety and Efficacy of Adalimumab in the Treatment of Hidradenitis SuppurativaCompletedNCT01635764Phase 3Results posted
• Crossover Study of Safety and Tolerability of Two Formulations of Adalimumab.CompletedNCT01561313Phase 2Results posted
• Vascular Inflammation in Psoriasis Trial (The VIP Trial)CompletedNCT01553058Phase 4Results posted
• A Study to Evaluate the Impact of Adalimumab on Quality of Life, Health Care Utilization and Costs of Ulcerative Colitis Subjects in the Usual Clinical Practice SettingCompletedNCT01550965Phase 3Results posted
• Pharmacokinetics and Safety Study of BI 695501 in Healthy SubjectsCompletedNCT01505491Phase 1Results posted
• A Crossover Study of the Safety and Tolerability of Two Formulations of AdalimumabCompletedNCT01502423Phase 2Results posted
• Study to Assess the Short- and Long-term Efficacy of Certolizumab Pegol Plus Methotrexate Compared to Adalimumab Plus Methotrexate in Subjects With Moderate to Severe Rheumatoid Arthritis (RA) Inadequately Responding to MethotrexateCompletedNCT01500278Phase 4Results posted
• Efficacy and Safety Study of Adalimumab in the Treatment of Hidradenitis SuppurativaCompletedNCT01468233Phase 3Results posted
• Efficacy and Safety Study of Adalimumab in Treatment of Hidradenitis SuppurativaCompletedNCT01468207Phase 3Results posted
• Cardiovascular Effects in Psoriasis Patients Treated With Adalimumab.CompletedNCT01320293Not applicableResults posted
• Efficacy Study of Adalimumab to Treat Interstitial CystitisCompletedNCT01295814Phase 3Results posted
• Immediate Response With Adalimumab and Its Impact on Quality of Life and Other Comorbidity Factors in Patients With Moderate to Severe Plaque PsoriasisCompletedNCT01265823Phase 4Results posted
• A Double Blind Study in Pediatric Subjects With Chronic Plaque Psoriasis, Studying Adalimumab vs. MethotrexateCompletedNCT01251614Phase 3Results posted
• A Study of Adalimumab in Japanese Subjects With Intestinal Behçet's DiseaseCompletedNCT01243671Phase 3Results posted
• Efficacy and Safety of Two Treatment Algorithms in Adults With Moderate to Severe Crohn's DiseaseCompletedNCT01235689Phase 3Results posted
• A Study of Adalimumab When Added to Inadequate Standard Anti-rheumatic Therapy in Patients With Active Rheumatoid ArthritisCompletedNCT01231321Phase 3Results posted
• Study to Determine the Effects of Different Doses of Methotrexate (MTX) When Taken With Adalimumab in Subjects With Early Rheumatoid Arthritis (RA)CompletedNCT01185301Phase 3Results posted
• A Study to Determine the Effect of Methotrexate (MTX) Dose on Clinical Outcome and Ultrasonographic Signs in Subjects With Moderately to Severely Active Rheumatoid Arthritis (RA) Treated With Adalimumab (MUSICA)CompletedNCT01185288Phase 4Results posted
• Intestinal Inflammation in Ankylosing Spondylitis and the Effects of Adalimumab on Mucosal HealingCompletedNCT01174186Phase 4Results posted
• A Study of the Efficacy and Safety of Adalimumab in Pediatric Subjects With Enthesitis Related ArthritisCompletedNCT01166282Phase 3Results posted
• A Canadian Study to Evaluate Early Use of Adalimumab After Methotrexate Failure in Early Rheumatoid ArthritisCompletedNCT01162421Phase 4Results posted
• A Study of the Long-term Safety and Efficacy of Adalimumab in Subjects With Intermediate-, Posterior-, or Pan-uveitisCompletedNCT01148225Phase 3Results posted
• Efficacy and Safety of Adalimumab in Patients With Active UveitisCompletedNCT01138657Phase 3Results posted
• Efficacy and Safety of Adalimumab in Subjects With Inactive UveitisCompletedNCT01124838Phase 3Results posted
• Efficacy and Safety of Adalimumab in Adult Chinese Subjects With Active Ankylosing SpondylitisCompletedNCT01114880Phase 3Results posted
• Remission in Subjects With Crohn's Disease, Open Label ExtensionCompletedNCT01070303Phase 3Results posted
• Study of Adalimumab in Participants With Peripheral Spondyloarthritis (SpA)CompletedNCT01064856Phase 3Results posted
• Study of Adalimumab in Patients With Axial SpondyloarthritisCompletedNCT00939003Phase 3Results posted
• Abatacept Versus Adalimumab Head-to-HeadCompletedNCT00929864Phase 3Results posted
• Safety and Efficacy of Adalimumab in Patients Who Showed an Unsatisfactory Response to EtanerceptCompletedNCT00927069Phase 3Results posted
• Study of Adalimumab in Subjects With Moderate to Severe Chronic Hidradenitis SuppurativaCompletedNCT00918255Phase 2Results posted
• A Study of Adalimumab in Japanese Subjects With Rheumatoid ArthritisCompletedNCT00870467Phase 3Results posted
• A Study of Adalimumab in Japanese Subjects With Moderately to Severely Active Ulcerative ColitisCompletedNCT00853099Phase 3Results posted
• Anti-TNF Agents for the Treatment of Rheumatoid ArthritisCompletedNCT00837434Phase 4Results posted
• Novel Therapies for Resistant FSGS (FONTII): Phase II Clinical TrialCompletedNCT00814255Phase 2Results posted
• Switching Anti-TNF-Alpha Agents in Rheumatoid Arthritis (RA)TerminatedNCT00796705Phase 4Results posted
• Active Juvenile Idiopathic Arthritis (JIA) Compassionate UseCompletedNCT00775437Phase 3Results posted
• Evaluation of Quality of Life Changes in Puerto Rican Subjects With Active Rheumatoid Arthritis Treated With HumiraTerminatedNCT00761514Phase 4Results posted
• Controlled Study of Humira in Subjects With Chronic Plaque Psoriasis of the Hands and/or FeetCompletedNCT00735787Phase 4Results posted
• Safety, Efficacy, and Pharmacokinetics of Adalimumab in Japanese Children With Juvenile Rheumatoid ArthritisCompletedNCT00690573Phase 3Results posted
• Efficacy and Long Term Safety of Adalimumab in Pediatric Subjects Who Have Demonstrated Clinical Response in M06-806CompletedNCT00686374Phase 3Results posted
• A Study of Adalimumab in Japanese Subjects With Active Ankylosing SpondylitisCompletedNCT00667355Phase 3Results posted
• Adalimumab in Adult Japanese Subjects With PsoriasisCompletedNCT00647400Phase 2/3Results posted
• Study Comparing 80 mg of Adalimumab With Placebo, and Demonstrating the Non-inferiority of Monthly 80 mg Adalimumab Dosing Compared With 40 mg Adalimumab Every Other Week DosingCompletedNCT00647270Phase 3Results posted
• Self-injection of Adalimumab in Adult Japanese Subjects With Rheumatoid ArthritisCompletedNCT00603993Phase 3Results posted
• Long-term Open-label Safety and Efficacy Study of Adalimumab in Subjects With Ulcerative ColitisCompletedNCT00573794Phase 3Results posted
• Open Label Study of Adalimumab in Subjects Who Have a Sub-optimal Response to Systemic Therapy or PhototherapyCompletedNCT00566722Phase 3Results posted
• Safety and Efficacy Study of Adalimumab in Adult Chinese Rheumatoid Arthritis Subjects Treated With MethotrexateCompletedNCT00538902Phase 2/3Results posted
• Adalimumab (Humira) in the Treatment of Refractory Non-infectious UveitisCompletedNCT00525902Phase 2Results posted
• A Canadian Open-Label Access Program to Evaluate Adalimumab When Added to Inadequate Therapy for the Treatment of PsoriasisCompletedNCT00513370Phase 3Results posted
• A Study of Adalimumab for the Induction of Clinical Remission in Japanese Subjects With Crohn's DiseaseCompletedNCT00445939Phase 2/3Results posted
• A Study of Adalimumab for the Maintenance of Clinical Remission in Japanese Subjects With Crohn's DiseaseCompletedNCT00445432Phase 2/3Results posted
• Human Anti-TNF Monoclonal Antibody Adalimumab in Canadian Subjects With Moderate to Severe Crohn's Disease (ACCESS)CompletedNCT00427921Phase 3Results posted
• Study of the Optimal Protocol for Methotrexate and Adalimumab Combination Therapy in Early Rheumatoid ArthritisCompletedNCT00420927Phase 4Results posted
• Efficacy and Safety of Adalimumab in Pediatric Subjects With Moderate to Severe Crohn's DiseaseCompletedNCT00409682Phase 3Results posted
• Study of Adalimumab Treatment for Induction and Maintenance of Clinical Remission in Subjects With Crohn's DiseaseCompletedNCT00409617Phase 3Results posted
• Efficacy and Safety of Adalimumab in Subjects With Moderately to Severely Active Ulcerative ColitisCompletedNCT00408629Phase 3Results posted
• Efficacy and Safety of Adalimumab in Subjects With Moderately to Severely Acute Ulcerative ColitisCompletedNCT00385736Phase 3Results posted
• Effects of Adalimumab on Mucosal Healing in Subjects With Crohn's Disease Involving the ColonCompletedNCT00348283Phase 3Results posted
• Trial of Adalimumab in Progressive SarcoidosisTerminatedNCT00311246Phase 2Results posted
• Adalimumab in Adult Japanese Subjects With Rheumatoid ArthritisCompletedNCT00235872Phase 3Results posted
• Adalimumab in Adult Japanese Subjects With Rheumatoid ArthritisCompletedNCT00235833Phase 2Results posted
• Safety and Efficacy of Adalimumab in Patients With Active Ankylosing SpondylitisCompletedNCT00195819Phase 3Results posted
• Long-term Safety and Tolerability Study of Adalimumab in Subjects With Crohn's DiseaseCompletedNCT00195715Phase 3Results posted
• Efficacy and Safety of Adalimumab in Patients With Active Rheumatoid Arthritis Treated Concomitantly With Methotrexate.CompletedNCT00195702Phase 3Results posted
• Efficacy and Safety of Adalimumab in Subjects With Moderate to Severe Chronic Plaque PsoriasisCompletedNCT00195676Phase 3Results posted
• Efficacy and Safety of Adalimumab and Methotrexate (MTX) Versus MTX Monotherapy in Subjects With Early Rheumatoid ArthritisCompletedNCT00195663Phase 3Results posted
• Long Term Open Label Continuation StudyCompletedNCT00195650Phase 3Results posted
• Human Anti-tumor Necrosis Factor (TNF) Monoclonal Antibody Adalimumab in Subjects With Active Ankylosing SpondylitisCompletedNCT00085644Phase 3Results posted
• Remission in Subjects With Crohn's Disease, 1 Year PhaseCompletedNCT00055497Phase 3Results posted
• Study of Human Anti-TNF Monoclonal Antibody Adalimumab in Children With Polyarticular Juvenile Idiopathic Arthritis (JIA)CompletedNCT00048542Phase 3Results posted
• Intravitreal Adalimumab in Inherited and Degenerative Retinal DiseasesActive, not recruitingNCT07348588Phase 1/2
• A Study of Pharmacokinetics, Safety, and Immunogenicity of BCD-057 100 mg/mL, BCD-057 50 mg/mL, and Humira 100 mg/mL in Healthy SubjectsCompletedNCT07181694Phase 1
• IKBKB Gene Polymorphism (Single Nucleotide Polymorphism) (SNP) in Psoriatic and Psoriatic Arthritis PatientsCompletedNCT06729463Not applicable
• A Study to Assess Adverse Events and Change in Disease Activity From Intravenous (IV) and Subcutaneous (SC) Lutikizumab in Adult Participants With Active Ulcerative ColitisActive, not recruitingNCT06257875Phase 2
• A Study of Vedolizumab Intravenous (IV) and Adalimumab or Vedolizumab and Ustekinumab in Adults With Crohn's DiseaseActive, not recruitingNCT06045754Phase 4
• Study to Determine the Pharmacokinetic (PK) Bioequivalence of ABP 501 and Adalimumab (Humira®) in Healthy Adult Japanese ParticipantsCompletedNCT05995691Phase 1
• A Study Comparing the Pharmacokinetics (PK) of ABP 501 40 mg/0.4 mL (ABP 501-HCF) and ABP 501 40 mg/0.8 ml (ABP 501-LCF) in Healthy Adult ParticipantsCompletedNCT05909852Phase 1
• A Study of Adalimumab on Inflammatory Mediators Following a Systemic Endotoxin ChallengeCompletedNCT05884242Phase 1
• Study to Assess Change in Disease Activity and Adverse Events of Oral Upadacitinib Compared to Subcutaneous Adalimumab in Adult Participants With Moderate to Severe Rheumatoid ArthritisCompletedNCT05814627Phase 3
• Using a Contact Dermatitis Model With Biologic Medications to Study Skin InflammationActive, not recruitingNCT05535738Phase 2/3
• The Clinical Efficacy and the Changes of Immune Cells Subsets With Bioagents in Ankylosing Spondylitis PatientsActive, not recruitingNCT05527444Phase 4
• A Study to Assess Change in Disease Activity and Adverse Events of Adalimumab in Chinese Participants Requiring High Dose Corticosteroids for Active Non-Infectious Intermediate, Posterior, or Pan-UveitisCompletedNCT05414201Phase 4
• Infliximab and Adalimumab in Inflammatory Bowel Disease Patients.CompletedNCT05291039Not applicable
• Study to Compare PK & Safety of Advixa With Humira in Healthy, Adult Subject Followed by Efficacy & Safety Study in RA PatientsStatus unknownNCT05172817Phase 2/3
• REduCed Dose of TNFi in Patients With Ankylosing SpondyliTis (RECAST)Status unknownNCT05164198Phase 4
• To Compare the Pharmacokinetics and Safety of PBP1502 and Humira in Healthy SubjectsActive, not recruitingNCT05108259Phase 1
• Experimental Medicine Studies of the Brain in Patients With Rheumatoid Arthritis REALISECompletedNCT05090124Not applicable
• The Efficacy and Safety of Adalimumab in Non-infectious Anterior Pediatric Uveitis With Peripheral Vascular LeakageStatus unknownNCT05015335Phase 4
• Study of Adalimumab or Placebo in Patients With Mild to Moderate COVID-19 (COMBAAT)WithdrawnNCT04705844Phase 3
• Adalimumab Plus Methotrexate for the Treatment of Pediatric UveitisStatus unknownNCT04588818Phase 2
• Pharmacokinetics, Safety, Tolerability, and Immunogenicity of Two Formulations of SB5 in Healthy Male SubjectsCompletedNCT04514796Phase 1
• Pharmacokinetic, Efficacy, Safety, and Immunogenicity of AVT02 With Moderate to Severe Chronic Plaque PsoriasisCompletedNCT04453137Phase 3
• Correlation of Serum Adalimumab Levels at an Administration of 40 mg Weekly vs 80 mg Every Two WeeksStatus unknownNCT04404517Phase 3
• Auto-injector Real Life Handling in PatientsCompletedNCT04224194Phase 3

← Adalimumab overview